At a glance
- Originator Nonindustrial source
- Class Heart failure therapies; Small molecules
- Mechanism of Action Nitric oxide synthase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Heart failure
Most Recent Events
- 11 Mar 1999 New profile
- 11 Mar 1999 Preclinical development for Heart failure in Latvia (Unknown route)